In conclusion, this study confirmed that IFIMT2 is highly expressed in CRC and the high expression of IFITM2 activates PI3K/AKT signaling pathway within tumor cells and promotes the proliferation and metastasis of CRC. The gene discussed is IFITM2; the disease is neoplasm.